首页 | 本学科首页   官方微博 | 高级检索  
     

云香十五味丸联合塞来昔布胶囊治疗膝骨关节炎的疗效观察
引用本文:孟利娜,乌云毕力格,白瑞蓉,霍宇军,刘梅,刘洋. 云香十五味丸联合塞来昔布胶囊治疗膝骨关节炎的疗效观察[J]. 现代药物与临床, 2021, 44(1): 137-141
作者姓名:孟利娜  乌云毕力格  白瑞蓉  霍宇军  刘梅  刘洋
作者单位:鄂尔多斯市中心医院 药剂科, 内蒙古 鄂尔多斯 017000;鄂尔多斯市中心医院 蒙医科, 内蒙古 鄂尔多斯 017000
基金项目:鄂尔多斯市中心医院院级课题(EY2017009)
摘    要:目的 研究云香十五味丸联合塞来昔布胶囊对膝骨关节炎患者的临床疗效。方法 选择2018年1月—2019年6月就诊于鄂尔多斯市中心医院的200例膝骨关节炎患者作为研究对象。对照组口服塞来昔布胶囊,0.2 g/次,1次/d。观察组在对照组基础上临睡前口服云香十五味丸,10粒/次,1次/d。两组均治疗3个月。治疗2周、1个月、3个月后,两组患者VAS积分均明显降低(P<0.05)。治疗1个月后,治疗组患者的VAS评分明显低于对照组(P<0.05)。治疗后,两组患者不同时间疼痛程度、僵硬程度、生活困难程度积分及WOMAC总积分均明显降低(P<0.05)。治疗2周,观察组患者晨起僵硬及WOMAC总积分明显低于对照组;治疗1个月,观察组各项目积分及WOMAC总积分均明显低于对照组(P<0.05)。治疗3个月,TESS评分变化较小,差异不具有统计学意义。结论 云香十五味丸联合塞来昔布胶囊能有效减轻膝骨关节炎患者疼痛,改善关节功能,具有一定的的临床推广价值。

关 键 词:云香十五味丸  塞来昔布胶囊  膝骨关节炎  疼痛评分  关节功能评分
收稿时间:2020-09-15

Effect observation on Yunxiang Shiwu Pills combined with Celecoxib Capsules in treatment of knee osteoarthritis
MENG Lin,WUYUN Bilige,BAI Ruirong,HUO Yujun,LIU Mei,LIU Yang. Effect observation on Yunxiang Shiwu Pills combined with Celecoxib Capsules in treatment of knee osteoarthritis[J]. Drugs & Clinic, 2021, 44(1): 137-141
Authors:MENG Lin  WUYUN Bilige  BAI Ruirong  HUO Yujun  LIU Mei  LIU Yang
Affiliation:Department of Pharmacy, Ordos Central Hospital, Ordos 017000, China;Department of Mongolian, Ordos Central Hospital, Ordos 017000, China
Abstract:Objective To study the clinical effectiveness of Yunxiang Shiwu Pills combined with Celecoxib Capsules in treatment of knee osteoarthritis. Methods A total of 200 patients with knee osteoarthritis who visited Ordos Central Hospital from January 2018 to June 2019 were selected as the study subjects. Patients in the control group were po administered with Celecoxib Capsules, 0.2 g/time, once daily. Patients in the observation group were po administered Yunxiang Shiwu Pills on the basis of control group, 10 pills/time, once daily. Both groups were treated for 3 months. After treatment, the changes of VAS, WOMAC, and TESS between two groups of patients before and, 2 weeks, 1 month, and 3 months after treatment were compared. Results After 2 weeks, 1 month and 3 months of treatment, VAS scores of patients in two groups were significantly reduced (P<0.05). After 1 month of treatment, VAS score of patients in the treatment group was significantly lower than that in the control group (P<0.05). After treatment, the pain degree, stiffness degree, life difficulty score, and WOMAC total score of two groups were significantly reduced at different times (P<0.05). Two weeks after treatment, morning stiffness and WOMAC score in the observation group were significantly lower than those in the control group. One month after treatment, the scores of each item and WOMAC in the observation group were significantly lower than those in the control group (P<0.05). TESS score changed little after 3 months of treatment, and the difference was not statistically significant. Conclusion Yunxiang Shiwu Pills combined with Celecoxib Capsules can effectively alleviate the pain and improve the joint function of patients with knee osteoarthritis, which has certain clinical promotion value.
Keywords:Yunxiang Shiwu Pills  Celecoxib Capsules  knee osteoarthritis  VAS score  WOMAC score
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号